Could a PET scan spare throat cancer patients from High-Dose radiation?

NCT ID NCT03416153

First seen Aug 07, 2026 ยท Last updated Aug 07, 2026

Summary

This trial tests a personalized approach to radiation therapy for people with HPV-related oropharynx cancer. Doctors use PET-CT scans taken before and during treatment to see how well the tumor is responding. If the response is good, the radiation dose is reduced, which may lessen side effects like difficulty swallowing and dry mouth. The study aims to see if this de-escalated approach can still control the cancer effectively while improving quality of life.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Radiation therapy with dose adjustment guided by PET-CT scans, combined with chemotherapy (carboplatin and paclitaxel)
What this could lead to
If successful, this approach could allow some patients with HPV-related throat cancer to receive lower radiation doses, potentially reducing side effects while maintaining high cure rates.
What could go wrong
This is a phase II trial with a relatively small number of participants. The main risk is that reducing radiation might increase the chance of cancer recurrence, and the study is designed to monitor this carefully.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV-RELATED SQUAMOUS CELL CARCINOMA OF THE OROPHARYNX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Michigan Hospital

    Ann Arbor, Michigan, 48109, United States

  • VA Ann Arbor Healthcare System

    Ann Arbor, Michigan, 48109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.